» Articles » PMID: 17849441

Dll3 and Notch1 Genetic Interactions Model Axial Segmental and Craniofacial Malformations of Human Birth Defects

Abstract

Mutations in the Notch1 receptor and delta-like 3 (Dll3) ligand cause global disruptions in axial segmental patterning. Genetic interactions between members of the notch pathway have previously been shown to cause patterning defects not observed in single gene disruptions. We examined Dll3-Notch1 compound mouse mutants to screen for potential gene interactions. While mice heterozygous at either locus appeared normal, 30% of Dll3-Notch1 double heterozygous animals exhibited localized, segmental anomalies similar to human congenital vertebral defects. Unexpectedly, double heterozygous mice also displayed statistically significant reduction of mandibular height and decreased length of the [corrected] maxillary hard palate. Examination of somite-stage embryos and perinatal anatomy and histology did not reveal any organ defects, so we used microarray-based analysis of Dll3 and Notch1 mutant embryos to identify gene targets that may be involved in notch-regulated segmental or craniofacial development. Thus, Dll3-Notch1 double heterozygous mice model human congenital scoliosis and craniofacial disorders.

Citing Articles

Species-specific roles of the Notch ligands, receptors, and targets orchestrating the signaling landscape of the segmentation clock.

Ramesh P, Chu L Front Cell Dev Biol. 2024; 11:1327227.

PMID: 38348091 PMC: 10859470. DOI: 10.3389/fcell.2023.1327227.


Whole Exome Sequencing of 23 Multigeneration Idiopathic Scoliosis Families Reveals Enrichments in Cytoskeletal Variants, Suggests Highly Polygenic Disease.

Terhune E, Wethey C, Cuevas M, Monley A, Baschal E, Bland M Genes (Basel). 2021; 12(6).

PMID: 34208743 PMC: 8235452. DOI: 10.3390/genes12060922.


Targeted sequencing of NOTCH signaling pathway genes and association analysis of variants correlated with mandibular prognathism.

Han X, Xiong X, Shi X, Chen F, Li Y Head Face Med. 2021; 17(1):17.

PMID: 34039391 PMC: 8152080. DOI: 10.1186/s13005-021-00268-0.


DLL3 expression is a predictive marker of sensitivity to adjuvant chemotherapy for pulmonary LCNEC.

Ogawa H, Sakai Y, Nishio W, Fujibayashi Y, Nishikubo M, Nishioka Y Thorac Cancer. 2020; 11(9):2561-2569.

PMID: 32691982 PMC: 7471044. DOI: 10.1111/1759-7714.13574.


Delta-like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy.

Matsuo K, Taniguchi K, Hamamoto H, Ito Y, Futaki S, Inomata Y Cancer Sci. 2019; 110(10):3122-3131.

PMID: 31369178 PMC: 6778628. DOI: 10.1111/cas.14157.